Riskpilot← Back to searchSign inGet full accessSAHA Invest AB
ABActiveOrg 5592166002Gustav Iii:S Boulevard 42Retail sale of pharmaceutical products · NACE 4773Est. 20190 employees
Revenue 2024
SEK 0
EBITDA margin
—
-14% vs 2023
Equity ratio
1.6%
Financial strength
Net profit 2024
SEK 10K
-95% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -115K | -14% |
| Net profit | SEK 10K | -95% |
| Total assets | SEK 4,1M | +0% |
| Equity | SEK 67K | +18% |
| Employees | 0 | — |
Legal name
SAHA Invest AB
Org number
5592166002
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
30 augusti 2019
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Rabiee, Sajjad
Company purpose
Bolaget har till föremål för sin verksamhet att förvalta aktier i bolag som bedriver apoteksverksamhet samt att, direkt eller indirekt, äga och förvalta övrig fast och lös egendom och därmed förenlig verksamhet.
Address
Gustav Iii:S Boulevard 42
Email
sajjad.ahmed@apoteksgruppen.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | −0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −39 | −49 | −149 | −101 | −115 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −39 | −49 | −149 | −101 | −115 |
| Net financials | −135 | −56 | −35 | −1 | 0 |
| Profit before tax | −173 | 167 | −184 | 198 | 14 |
| Tax | −0 | −0 | — | −2 | −4 |
| Net profit | −173 | 167 | −184 | 196 | 10 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 046 | 4 022 | 4 042 | 4 063 | 4 055 |
| Equity | −123 | 44 | −140 | 57 | 67 |
| Long-term debt | 3 719 | 3 528 | 3 732 | 3 555 | 3 515 |
| Short-term debt | 450 | 450 | 450 | 452 | 474 |
| Total debt | 4 169 | 3 978 | 4 182 | 4 007 | 3 988 |
EBITDA margin
-11496700.0%
This company
15.8%
Market median
-72764024% vs market
20202024
Equity ratio
1.6%
This company
38.2%
Market median
-96% vs market
20202024
Return on equity
15.1%
This company
18.4%
Market median
+18% vs market
20202024
Net profit margin
1007300.0%
This company
8.1%
Market median
+12435702% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
59.76×
This company
0.62×
Market median
-9539% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-08-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ME Chief Auditor | Chief Auditor | 2025 |
HJ Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 |
| Former (1) | ||
JL Audit | Audit | 2025 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SAHA Invest AB 
Närapoteket i Frösunda ABBoard members of SAHA Invest AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malin Elisabeth Terneblad | Chief Auditor | 0 companies |
| Haider Javad Naser | Deputy Chief Executive Officer | 0 companies |
| Jonas Lars Lindgren | Audit | 0 companies |
| Mohammad Rabiee | Deputy Board Member | 0 companies |
| Sajjad Rabiee | Chairman | 0 companies |